We are live on ! Find out more
MME

Meag Munich Ergo Portfolio holdings

AUM $3.54B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+20%
3 Year Est. Return
+82.79%
5 Year Est. Return
+144.54%
10 Year Est. Return
+335.02%
AUM
$1.41B
AUM Growth
+$833M
Cap. Flow
+$768M
Cap. Flow %
54.53%
Top 10 Hldgs %
29.38%
Holding
246
New
36
Increased
47
Reduced
42
Closed
48

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$42M
2
UNH icon
UnitedHealth
UNH
+$41.6M
3
CSCO icon
Cisco
CSCO
+$41.1M
4
GD icon
General Dynamics
GD
+$37.7M
5
MET icon
MetLife
MET
+$37.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$11.8M
2
DIS icon
Walt Disney
DIS
+$7.85M
3
CI icon
Cigna
CI
+$7.3M
4
INTC icon
Intel
INTC
+$6.94M
5
LW icon
Lamb Weston
LW
+$6.24M

Sector Composition

Rank Sector Weight
1 Financials 19.08%
2 Technology 17.7%
3 Healthcare 16.44%
4 Industrials 10.23%
5 Consumer Discretionary 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
151
Humana
HUM
$43.7B
$368K 0.03%
787
– –
CSX icon
152
CSX Corp
CSX
$93.4B
$346K 0.02%
9,243
– –
SBUX icon
153
Starbucks
SBUX
$120B
$346K 0.02%
2,964
– –
HIG icon
154
Hartford Financial Services
HIG
$38.9B
$344K 0.02%
4,952
– –
AMGN icon
155
Amgen
AMGN
$208B
$341K 0.02%
1,500
-15,946
-91% -$3.37M
BMY icon
156
Bristol-Myers Squibb
BMY
$133B
$339K 0.02%
5,400
– –
CME icon
157
CME Group
CME
$96.3B
$324K 0.02%
1,410
– –
AMT icon
158
American Tower
AMT
$80.8B
$314K 0.02%
1,076
– –
MLCO icon
159
Melco Resorts & Entertainment
MLCO
$2.22B
$312K 0.02%
30,500
– –
GILD icon
160
Gilead Sciences
GILD
$162B
$309K 0.02%
4,200
– –
NEM icon
161
Newmont
NEM
$98.7B
$309K 0.02%
5,000
-22,096
-82% -$1.25M
LRCX icon
162
Lam Research
LRCX
$367B
$307K 0.02%
4,260
-23,950
-85% -$1.5M
WY icon
163
Weyerhaeuser
WY
$18B
$302K 0.02%
7,346
– –
CAT icon
164
Caterpillar
CAT
$375B
$300K 0.02%
1,452
-15,055
-91% -$3.03M
FUTU icon
165
Futu Holdings
FUTU
$14.7B
$276K 0.02%
6,400
– –
GAP
166
The Gap Inc
GAP
$7.23B
$269K 0.02%
+15,000
New +$314K
TMO icon
167
Thermo Fisher Scientific
TMO
$213B
$267K 0.02%
400
– –
BKNG icon
168
Booking.com
BKNG
$149B
$255K 0.02%
2,650
– –
UNP icon
169
Union Pacific
UNP
$174B
$251K 0.02%
1,004
-18,493
-95% -$4.38M
CI icon
170
Cigna
CI
$73.7B
$243K 0.02%
1,050
-34,344
-97% -$7.3M
COP icon
171
ConocoPhillips
COP
$147B
$243K 0.02%
3,343
– –
PGR icon
172
Progressive
PGR
$123B
$241K 0.02%
2,335
– –
RCI icon
173
Rogers Communications
RCI
$18.3B
$238K 0.02%
5,039
– –
WEC icon
174
WEC Energy
WEC
$35.7B
$231K 0.02%
2,370
– –
WMB icon
175
Williams Companies
WMB
$87.5B
$229K 0.02%
8,818
– –
5 6
7
8 9

Similar funds

FHA
First Horizon Advisors Memphis, Tennessee $3.85B AUM 16.99% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
MC
Martin Currie Edinburgh, United Kingdom $2.61B AUM 29.41% 1-Year Est. Return
CIA
ClearBridge Investments (Australia) Sydney, Australia $4.56B AUM 24.16% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
WBA
Walgreens Boots Alliance Deerfield, Illinois $2.24B AUM 36.34% 1-Year Est. Return
MD
Money Design Tokyo, Japan $2.14B AUM 10.33% 1-Year Est. Return
GL
Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return

Meag Munich Ergo's Q4 2021 Portfolio in Review

As of Q4 2021, Meag Munich Ergo held 246 positions worth $1.41B, up 145% from $575M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Meag Munich Ergo deployed $768M of net new capital in Q4 2021, opening 36 new positions and adding to 47 existing holdings. Its largest new stake was Morgan Stanley: 421,792 shares worth $41.8M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $11.8M trimmed.

  • Meag Munich Ergo's largest Q4 2021 buy was Morgan Stanley: 421,792 shares worth $41.8M.
  • Meag Munich Ergo added most to Cisco in Q4 2021, an estimated $41.1M increase.
  • Meag Munich Ergo's biggest Q4 2021 reduction was Johnson & Johnson, cutting an estimated $11.8M.
  • Meag Munich Ergo fully exited Lamb Weston in Q4 2021, selling an estimated $6.24M.
  • Meag Munich Ergo's ten largest holdings make up 29% of its $1.41B portfolio in Q4 2021.
  • Meag Munich Ergo opened 36 new positions and closed 48 in Q4 2021.
  • Meag Munich Ergo's portfolio value rose 145% quarter-over-quarter to $1.41B.

Based on Meag Munich Ergo's 13F filing for Q4 2021, filed 25 Jan 2022.